Global POC Diagnostics Industry Growth and Trends Forecast to 2031
Description
Summary
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
According to APO Research, The global POC Diagnostics market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for POC Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for POC Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for POC Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of POC Diagnostics include Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter and Nipro Diagnostics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for POC Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC Diagnostics.
The POC Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global POC Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
POC Diagnostics Segment by Company
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
POC Diagnostics Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas or Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
POC Diagnostics Segment by Application
Clinics
Hospitals
Laboratory
Others
POC Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global POC Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of POC Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of POC Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of POC Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of POC Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
According to APO Research, The global POC Diagnostics market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for POC Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for POC Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for POC Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of POC Diagnostics include Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter and Nipro Diagnostics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for POC Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC Diagnostics.
The POC Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global POC Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
POC Diagnostics Segment by Company
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
POC Diagnostics Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas or Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
POC Diagnostics Segment by Application
Clinics
Hospitals
Laboratory
Others
POC Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global POC Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of POC Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of POC Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of POC Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of POC Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
115 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global POC Diagnostics Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global POC Diagnostics Sales Estimates and Forecasts (2020-2031)
- 1.3 POC Diagnostics Market by Type
- 1.3.1 Blood Glucose Testing
- 1.3.2 Infectious Diseases Testing
- 1.3.3 Cardiac Markers Testing
- 1.3.4 Coagulation Testing
- 1.3.5 Pregnancy and Fertility Testing
- 1.3.6 Blood Gas or Electrolytes Testing
- 1.3.7 Tumor Markers Testing
- 1.3.8 Urinalysis Testing
- 1.3.9 Cholesterol Testing
- 1.3.10 Others
- 1.4 Global POC Diagnostics Market Size by Type
- 1.4.1 Global POC Diagnostics Market Size Overview by Type (2020-2031)
- 1.4.2 Global POC Diagnostics Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global POC Diagnostics Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America POC Diagnostics Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe POC Diagnostics Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific POC Diagnostics Sales Breakdown by Type (2020-2025)
- 1.5.4 South America POC Diagnostics Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa POC Diagnostics Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 POC Diagnostics Industry Trends
- 2.2 POC Diagnostics Industry Drivers
- 2.3 POC Diagnostics Industry Opportunities and Challenges
- 2.4 POC Diagnostics Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by POC Diagnostics Revenue (2020-2025)
- 3.2 Global Top Players by POC Diagnostics Sales (2020-2025)
- 3.3 Global Top Players by POC Diagnostics Price (2020-2025)
- 3.4 Global POC Diagnostics Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global POC Diagnostics Major Company Production Sites & Headquarters
- 3.6 Global POC Diagnostics Company, Product Type & Application
- 3.7 Global POC Diagnostics Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global POC Diagnostics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 POC Diagnostics Players Market Share by Revenue in 2024
- 3.8.3 2023 POC Diagnostics Tier 1, Tier 2, and Tier 3
- 4 POC Diagnostics Regional Status and Outlook
- 4.1 Global POC Diagnostics Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global POC Diagnostics Historic Market Size by Region
- 4.2.1 Global POC Diagnostics Sales in Volume by Region (2020-2025)
- 4.2.2 Global POC Diagnostics Sales in Value by Region (2020-2025)
- 4.2.3 Global POC Diagnostics Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global POC Diagnostics Forecasted Market Size by Region
- 4.3.1 Global POC Diagnostics Sales in Volume by Region (2026-2031)
- 4.3.2 Global POC Diagnostics Sales in Value by Region (2026-2031)
- 4.3.3 Global POC Diagnostics Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 POC Diagnostics by Application
- 5.1 POC Diagnostics Market by Application
- 5.1.1 Clinics
- 5.1.2 Hospitals
- 5.1.3 Laboratory
- 5.1.4 Others
- 5.2 Global POC Diagnostics Market Size by Application
- 5.2.1 Global POC Diagnostics Market Size Overview by Application (2020-2031)
- 5.2.2 Global POC Diagnostics Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global POC Diagnostics Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America POC Diagnostics Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe POC Diagnostics Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific POC Diagnostics Sales Breakdown by Application (2020-2025)
- 5.3.4 South America POC Diagnostics Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa POC Diagnostics Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Alere
- 6.1.1 Alere Comapny Information
- 6.1.2 Alere Business Overview
- 6.1.3 Alere POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Alere POC Diagnostics Product Portfolio
- 6.1.5 Alere Recent Developments
- 6.2 Roche
- 6.2.1 Roche Comapny Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Roche POC Diagnostics Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Abbott Laboratories
- 6.3.1 Abbott Laboratories Comapny Information
- 6.3.2 Abbott Laboratories Business Overview
- 6.3.3 Abbott Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Abbott Laboratories POC Diagnostics Product Portfolio
- 6.3.5 Abbott Laboratories Recent Developments
- 6.4 Johnson & Johnson
- 6.4.1 Johnson & Johnson Comapny Information
- 6.4.2 Johnson & Johnson Business Overview
- 6.4.3 Johnson & Johnson POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Johnson & Johnson POC Diagnostics Product Portfolio
- 6.4.5 Johnson & Johnson Recent Developments
- 6.5 Siemens Healthcare
- 6.5.1 Siemens Healthcare Comapny Information
- 6.5.2 Siemens Healthcare Business Overview
- 6.5.3 Siemens Healthcare POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Siemens Healthcare POC Diagnostics Product Portfolio
- 6.5.5 Siemens Healthcare Recent Developments
- 6.6 Danaher
- 6.6.1 Danaher Comapny Information
- 6.6.2 Danaher Business Overview
- 6.6.3 Danaher POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Danaher POC Diagnostics Product Portfolio
- 6.6.5 Danaher Recent Developments
- 6.7 Bayer Healthcare
- 6.7.1 Bayer Healthcare Comapny Information
- 6.7.2 Bayer Healthcare Business Overview
- 6.7.3 Bayer Healthcare POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.7.4 Bayer Healthcare POC Diagnostics Product Portfolio
- 6.7.5 Bayer Healthcare Recent Developments
- 6.8 Beckman Coulter
- 6.8.1 Beckman Coulter Comapny Information
- 6.8.2 Beckman Coulter Business Overview
- 6.8.3 Beckman Coulter POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.8.4 Beckman Coulter POC Diagnostics Product Portfolio
- 6.8.5 Beckman Coulter Recent Developments
- 6.9 Nipro Diagnostics
- 6.9.1 Nipro Diagnostics Comapny Information
- 6.9.2 Nipro Diagnostics Business Overview
- 6.9.3 Nipro Diagnostics POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.9.4 Nipro Diagnostics POC Diagnostics Product Portfolio
- 6.9.5 Nipro Diagnostics Recent Developments
- 6.10 Bio-Rad Laboratories
- 6.10.1 Bio-Rad Laboratories Comapny Information
- 6.10.2 Bio-Rad Laboratories Business Overview
- 6.10.3 Bio-Rad Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.10.4 Bio-Rad Laboratories POC Diagnostics Product Portfolio
- 6.10.5 Bio-Rad Laboratories Recent Developments
- 6.11 Nova Biomedical
- 6.11.1 Nova Biomedical Comapny Information
- 6.11.2 Nova Biomedical Business Overview
- 6.11.3 Nova Biomedical POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.11.4 Nova Biomedical POC Diagnostics Product Portfolio
- 6.11.5 Nova Biomedical Recent Developments
- 6.12 BioMerieux
- 6.12.1 BioMerieux Comapny Information
- 6.12.2 BioMerieux Business Overview
- 6.12.3 BioMerieux POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.12.4 BioMerieux POC Diagnostics Product Portfolio
- 6.12.5 BioMerieux Recent Developments
- 6.13 Quidel
- 6.13.1 Quidel Comapny Information
- 6.13.2 Quidel Business Overview
- 6.13.3 Quidel POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.13.4 Quidel POC Diagnostics Product Portfolio
- 6.13.5 Quidel Recent Developments
- 6.14 Helena Laboratories
- 6.14.1 Helena Laboratories Comapny Information
- 6.14.2 Helena Laboratories Business Overview
- 6.14.3 Helena Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.14.4 Helena Laboratories POC Diagnostics Product Portfolio
- 6.14.5 Helena Laboratories Recent Developments
- 6.15 OraSure Technologies
- 6.15.1 OraSure Technologies Comapny Information
- 6.15.2 OraSure Technologies Business Overview
- 6.15.3 OraSure Technologies POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.15.4 OraSure Technologies POC Diagnostics Product Portfolio
- 6.15.5 OraSure Technologies Recent Developments
- 6.16 Accriva
- 6.16.1 Accriva Comapny Information
- 6.16.2 Accriva Business Overview
- 6.16.3 Accriva POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.16.4 Accriva POC Diagnostics Product Portfolio
- 6.16.5 Accriva Recent Developments
- 6.17 Abaxis
- 6.17.1 Abaxis Comapny Information
- 6.17.2 Abaxis Business Overview
- 6.17.3 Abaxis POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.17.4 Abaxis POC Diagnostics Product Portfolio
- 6.17.5 Abaxis Recent Developments
- 6.18 Chembio Diagnostics
- 6.18.1 Chembio Diagnostics Comapny Information
- 6.18.2 Chembio Diagnostics Business Overview
- 6.18.3 Chembio Diagnostics POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.18.4 Chembio Diagnostics POC Diagnostics Product Portfolio
- 6.18.5 Chembio Diagnostics Recent Developments
- 6.19 Trinity Biotech
- 6.19.1 Trinity Biotech Comapny Information
- 6.19.2 Trinity Biotech Business Overview
- 6.19.3 Trinity Biotech POC Diagnostics Sales, Revenue and Gross Margin (2020-2025)
- 6.19.4 Trinity Biotech POC Diagnostics Product Portfolio
- 6.19.5 Trinity Biotech Recent Developments
- 7 North America by Country
- 7.1 North America POC Diagnostics Sales by Country
- 7.1.1 North America POC Diagnostics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America POC Diagnostics Sales by Country (2020-2025)
- 7.1.3 North America POC Diagnostics Sales Forecast by Country (2026-2031)
- 7.2 North America POC Diagnostics Market Size by Country
- 7.2.1 North America POC Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America POC Diagnostics Market Size by Country (2020-2025)
- 7.2.3 North America POC Diagnostics Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe POC Diagnostics Sales by Country
- 8.1.1 Europe POC Diagnostics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe POC Diagnostics Sales by Country (2020-2025)
- 8.1.3 Europe POC Diagnostics Sales Forecast by Country (2026-2031)
- 8.2 Europe POC Diagnostics Market Size by Country
- 8.2.1 Europe POC Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe POC Diagnostics Market Size by Country (2020-2025)
- 8.2.3 Europe POC Diagnostics Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific POC Diagnostics Sales by Country
- 9.1.1 Asia-Pacific POC Diagnostics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific POC Diagnostics Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific POC Diagnostics Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific POC Diagnostics Market Size by Country
- 9.2.1 Asia-Pacific POC Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific POC Diagnostics Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific POC Diagnostics Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America POC Diagnostics Sales by Country
- 10.1.1 South America POC Diagnostics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America POC Diagnostics Sales by Country (2020-2025)
- 10.1.3 South America POC Diagnostics Sales Forecast by Country (2026-2031)
- 10.2 South America POC Diagnostics Market Size by Country
- 10.2.1 South America POC Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America POC Diagnostics Market Size by Country (2020-2025)
- 10.2.3 South America POC Diagnostics Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa POC Diagnostics Sales by Country
- 11.1.1 Middle East and Africa POC Diagnostics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa POC Diagnostics Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa POC Diagnostics Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa POC Diagnostics Market Size by Country
- 11.2.1 Middle East and Africa POC Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa POC Diagnostics Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa POC Diagnostics Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 POC Diagnostics Value Chain Analysis
- 12.1.1 POC Diagnostics Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 POC Diagnostics Production Mode & Process
- 12.2 POC Diagnostics Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 POC Diagnostics Distributors
- 12.2.3 POC Diagnostics Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


